Phase 2 study to evaluate the clinical efficacy and safety of MEDI4736 in patients with glioblastoma (GBM) Reardon, D. A., Dietrich, J., Kaley, T., Gan, H., Dunn, G. P., Cloughesy, T., Lim, M., Clarke, J., Park, A., Pang, L., Lai, D. W., Karakunnel, J., Robbins, P., Narwal, R., Venhaus, R. AMER ASSOC CANCER RESEARCH. 2016

View details for DOI 10.1158/2326-6074.CRICIMTEATIAACR15-A046

View details for Web of Science ID 000375484400041